Flatiron Health’s Post

The #cancer clinical trial landscape in the U.S. is complex: less than 5% of adult cancer patients enroll in clinical trials and a lack of participant diversity leads to inequities in cancer care. Learn three ways our PINC AI™ Applied Sciences division is working with #healthcare organizations, life sciences and medical device companies to drive greater participation and diversity in clinical trials: https://lnkd.in/ebRgEPRg

Blue Earth Diagnostics, Inc. is committed to pushing the boundaries of cancer management through scientific exploration. Our clinical trials are instrumental in unraveling the mysteries of cancer, providing valuable insights into effective diagnosis and treatment. Our focus extends beyond developing new imaging technologies; we're also dedicated to exploring alternative uses for existing imaging technologies. This expanded approach is essential for addressing diverse patient needs and improving healthcare outcomes. The results from these trials undergo rigorous scrutiny by regulatory authorities, ensuring that our innovations meet the highest standards of safety and efficacy. Together, we're shaping the future of cancer care! Learn more about our clinical trial work at https://lnkd.in/eA3MX7ij #BlueEarthDx #ClinicalTrials #CancerCare #MedicalInnovation

Embracing the integration of physical therapy in cancer survivors' care is a key move that many businesses often overlook. UPMC's Hillman Cancer Center's initiative in offering a multidisciplinary survivorship program showcases the vast opportunities in the field, not only in oncology rehabilitation but also in extending services through virtual platforms. Is your business keen on exploring these opportunities? Are you maximizing the full potential of #PhysicalTherapy in transdisciplinary patient care? If you find yourself grappling with these questions, I, Jim Tomasin, MSPT, am here to provide professional insights into leveraging #PhysicalTherapy for a more comprehensive patient care strategy and to assist in the transition to the use of virtual platforms for consultations. Let's discuss how we can elevate the standard of care for cancer survivors and beyond. #OncologyRehabilitation #Telehealth

We're busy at #ASCO24 advocating with researchers, clinicians, biotech firms and industry to continue working on ways to improve outcomes and care for our ALK and wider cancer community. Here Kenneth Culver MD, Director of Research & Clinical Affairs, at ALK Positive, updates us on what we get up to at industry meetings like ASCO. #research #curecancer #hope #researchsaveslives #lungcancer

Can't wait to spend some time in DC with key stakeholders in oncology, presenting on how we can work to ensure quality and safety in AI tools in healthcare. It is a crucial time to take a close look at how we are evaluating and using artificial intelligence in healthcare, an industry where AI has immense opportunity but also poses significant risk.

On World Cancer Day 2024, let's reflect on the current trends in digital health innovation toward cancer patients: - Trend towards out-of-hospital-administration - Precision medicine's rise - Digital health role in oncology Read our complete article: https://lnkd.in/ec2u8-B2 #WorldCancerDay  #CancerAwareness

Going through cancer treatment is a uniquely stressful and exhausting experience — how can design mitigate the stress and do its part to support the patients? Shane Williams AIA, ACHA, Lean Six Sigma Healthcare, Healthcare Studio Design Director, explores how common typologies can be improved and rethought for improved patient experience across cancer centers. Learn more about enhancing user experience at cancer clinics: https://bit.ly/3UwwPHV

🌆 It is #ASCO24 Time! We are thrilled to be Chicago for the American Society of Clinical Oncology (ASCO) meeting this weekend. 🔬 This year's theme 'The Art and Science of Cancer Care: From Comfort to Cure' was chosen by ASCO President Dr. Lynn Schuchter to, "capture both the unprecedented progress we have made in cancer treatment, which is leading to better outcomes, and often cures, for some patients, and the recognition that these advances are not benefiting all patients" Realyze Intelligence offers solutions that can accelerate inclusive deployment of research as care & tools that empower clinicians to use real-world data to continue innovating for both today & tomorrow's patients. Find us at McCormick or schedule time below - we have exciting meetings lined up with current collaborators & are looking forward to meeting new partners! 🗓 https://lnkd.in/gn5DsJkT #ASCO24 #AIinPrecisionMedicine #ResearchAsCare #ClinicalTrialsForAll #AIOncology #CloseTheCareGap #NoMoreZombieTrials #RealyzeIntelligence

🎙️ Delve into the future of cancer care with Kathy Dalton Ford, Chief Product and Strategy Officer of Ronin, in the latest episode of #FriendsofProjectHealthcare! Discover how predictive analytics and personalized medicine are reshaping cancer treatment, as Ronin collaborates with Oracle Health to tackle challenges in this field. Eric Thrailkill

The Medical World is constantly evolving, impacting how we access care and the frequency of recommended screenings. "In the Loop" explores the recent changes, by the U.S. Preventative Services Task Force, in Breast Cancer Screening recommendations and sheds light on the rationale behind these updates. Additionally, the article delves into valuable insights on Ozempic. Stay informed with the latest developments in healthcare. #HealthcareUpdates #employeebenefits